The presence of genomic instability, mainly driven by mutations in BRCA1/2 as well as other genes of the homologous recombination repair pathway, determines pathogenesis in high-grade serous carcinomas and to a lesser extent high-grade endometrioid carcinomas [32]. The gene discussed is BRCA1; the disease is endometrioid adenocarcinoma.